![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CAMTA2 |
Gene summary for CAMTA2 |
![]() |
Gene information | Species | Human | Gene symbol | CAMTA2 | Gene ID | 23125 |
Gene name | calmodulin binding transcription activator 2 | |
Gene Alias | CAMTA2 | |
Cytomap | 17p13.2 | |
Gene Type | protein-coding | GO ID | GO:0003008 | UniProtAcc | O94983 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23125 | CAMTA2 | LZE4T | Human | Esophagus | ESCC | 6.20e-03 | 1.44e-01 | 0.0811 |
23125 | CAMTA2 | LZE7T | Human | Esophagus | ESCC | 1.78e-03 | 1.83e-01 | 0.0667 |
23125 | CAMTA2 | LZE24T | Human | Esophagus | ESCC | 4.40e-08 | 2.17e-01 | 0.0596 |
23125 | CAMTA2 | P4T-E | Human | Esophagus | ESCC | 6.42e-06 | 1.80e-01 | 0.1323 |
23125 | CAMTA2 | P5T-E | Human | Esophagus | ESCC | 4.06e-06 | 1.74e-01 | 0.1327 |
23125 | CAMTA2 | P8T-E | Human | Esophagus | ESCC | 1.36e-11 | 2.88e-01 | 0.0889 |
23125 | CAMTA2 | P9T-E | Human | Esophagus | ESCC | 2.98e-02 | 1.21e-01 | 0.1131 |
23125 | CAMTA2 | P10T-E | Human | Esophagus | ESCC | 5.73e-05 | 1.48e-01 | 0.116 |
23125 | CAMTA2 | P11T-E | Human | Esophagus | ESCC | 3.43e-06 | 4.78e-01 | 0.1426 |
23125 | CAMTA2 | P12T-E | Human | Esophagus | ESCC | 1.28e-04 | 1.12e-01 | 0.1122 |
23125 | CAMTA2 | P15T-E | Human | Esophagus | ESCC | 8.02e-04 | 6.86e-02 | 0.1149 |
23125 | CAMTA2 | P16T-E | Human | Esophagus | ESCC | 2.16e-05 | 2.07e-01 | 0.1153 |
23125 | CAMTA2 | P17T-E | Human | Esophagus | ESCC | 1.79e-03 | 2.21e-01 | 0.1278 |
23125 | CAMTA2 | P19T-E | Human | Esophagus | ESCC | 5.80e-07 | 5.50e-01 | 0.1662 |
23125 | CAMTA2 | P21T-E | Human | Esophagus | ESCC | 5.13e-34 | 6.40e-01 | 0.1617 |
23125 | CAMTA2 | P22T-E | Human | Esophagus | ESCC | 3.72e-12 | 1.85e-01 | 0.1236 |
23125 | CAMTA2 | P23T-E | Human | Esophagus | ESCC | 7.36e-03 | 9.29e-02 | 0.108 |
23125 | CAMTA2 | P24T-E | Human | Esophagus | ESCC | 5.13e-09 | 2.72e-01 | 0.1287 |
23125 | CAMTA2 | P27T-E | Human | Esophagus | ESCC | 1.41e-05 | 1.17e-01 | 0.1055 |
23125 | CAMTA2 | P28T-E | Human | Esophagus | ESCC | 4.36e-11 | 1.72e-01 | 0.1149 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CAMTA2 | SNV | Missense_Mutation | rs779236594 | c.1093N>G | p.Arg365Gly | p.R365G | O94983 | protein_coding | deleterious_low_confidence(0.01) | probably_damaging(0.942) | TCGA-E6-A2P8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
CAMTA2 | SNV | Missense_Mutation | novel | c.120N>T | p.Lys40Asn | p.K40N | O94983 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.999) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CAMTA2 | SNV | Missense_Mutation | novel | c.3485G>A | p.Arg1162His | p.R1162H | O94983 | protein_coding | deleterious(0) | possibly_damaging(0.908) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CAMTA2 | SNV | Missense_Mutation | novel | c.1022N>T | p.Ser341Phe | p.S341F | O94983 | protein_coding | deleterious_low_confidence(0) | benign(0.08) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
CAMTA2 | SNV | Missense_Mutation | novel | c.2925G>T | p.Glu975Asp | p.E975D | O94983 | protein_coding | tolerated(0.27) | possibly_damaging(0.82) | TCGA-EO-A3KX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CAMTA2 | SNV | Missense_Mutation | novel | c.2543N>C | p.Leu848Pro | p.L848P | O94983 | protein_coding | tolerated(0.42) | benign(0.001) | TCGA-EY-A1GQ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | taxol | SD |
CAMTA2 | SNV | Missense_Mutation | novel | c.3317N>A | p.Arg1106Gln | p.R1106Q | O94983 | protein_coding | deleterious(0) | probably_damaging(0.921) | TCGA-EY-A215-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CAMTA2 | SNV | Missense_Mutation | novel | c.2406C>A | p.Asn802Lys | p.N802K | O94983 | protein_coding | deleterious(0) | possibly_damaging(0.867) | TCGA-EY-A2OM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | taxol | SD |
CAMTA2 | insertion | Frame_Shift_Ins | novel | c.1475_1476insTTCT | p.Pro493SerfsTer29 | p.P493Sfs*29 | O94983 | protein_coding | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD | ||
CAMTA2 | insertion | Frame_Shift_Ins | novel | c.1473_1474insGGTAGCCAGAGAAGGAGCCAGGGAAAGAGAGC | p.Pro492GlyfsTer25 | p.P492Gfs*25 | O94983 | protein_coding | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |